Lorlatinib

Definition: Lorlatinib, sold under the brand name Lorbrena in the United States, Canada, and Japan, and Lorviqua in the European Union, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is an orally administered inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1), two enzymes that play a role in the development of cancer. It was developed by Pfizer. source: Wikipedia

ID

782996004

Name

Lorlatinib

Previous ID

37615911000001100

ID date

6 Feb 2023